Clinical Trials Logo

HIV Vaccine clinical trials

View clinical trials related to HIV Vaccine.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05786937 Not yet recruiting - HIV Vaccine Clinical Trials

Therapeutic Vaccine Based on aDC1 Dendritic Cells for the Control of Viremia After ATI in HIV Infected Individuals

Start date: June 2023
Phase: Phase 1
Study type: Interventional

The goal of this interventional study is to validate the strategy of adjuvant therapy with dendritic cells in HIV infection in chronically infected individuals. The main questions it aims to answer are related to the safety and tolerance of the intervention and the virological and immunological impact of immunotherapy with aDC1 in HIV-infected individuals. The study will include 30 diagnosed HIV-infected patients, using antiretroviral therapy, who will be immunized with aDC1 or placebo according to the arms of this study: G1) placebo; G2) aDC1immunization; G3) aDC1 immunization with analytical treatment interruption of ART.